Sector pending / In Vitro and In Vivo Diagnostic SubstancesUpdated 2026-05-10 22:07 UTC

FRA/IX1 stock hub

FRA/IX1 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

FRA/IX1is not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

37.5B

Frankfurt Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

FRA/IX1

In the news

Latest news · FRA/IX1

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E36.9

P25 n/aP50 n/aP75 n/a

Trailing P/E39.5

P25 n/aP50 n/aP75 n/a

ROE72.9

P25 n/aP50 n/aP75 n/a

ROIC46

P25 n/aP50 n/aP75 n/a

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All FRA/IX1 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

219

Groups with data

Currency

USD

Showing 219 of 219 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	United States
Country code	DE
Employees	11,000
Employees Change	0%
Employees Change Percent	0
Enterprise value	EUR 38.3B
Exchange	Frankfurt Stock Exchange
Financial currency	USD
First seen	2026-05-10
Industry	In Vitro and In Vivo Diagnostic Substances
Last refreshed	2026-05-10
Market cap	EUR 37.5B
Price	EUR 486
Price currency	EUR
Rev Per Employee	350,554.38x
Sic	2835
Symbol	fra/IX1
Website	https://www.idexx.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	2.53%
EV Earnings	40.33x
EV/EBIT	32.27x
EV/EBITDA	28.44x
EV/FCF	40.77x
EV/Sales	10.14x
FCF yield	2.5%
Forward P/E	36.89x
P/B ratio	27.81x
P/E ratio	39.52x
P/S ratio	9.73x
PE Ratio10 Y	53.41x
PE Ratio3 Y	46.67x
PE Ratio5 Y	51.78x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	31.42%
EBITDA Margin	34.77%
FCF margin	24.37%
Gross margin	62.05%
Gross Profit	EUR 2.4B
Gross Profit Growth	14.52%
Gross Profit Growth Q	15.94%
Gross Profit Growth3 Y	10.43%
Gross Profit Growth5 Y	10.4%
Net Income	EUR 949.9M
Net Income Growth	22.38%
Net Income Growth Q	14.74%
Net Income Growth3 Y	16.14%
Net Income Growth5 Y	10.19%
Pretax Margin	30.8%
Profit Margin	24.63%
Profit Per Employee	EUR 86,354
ROA	26.46
Roa5y	23.48
ROCE	66.99
ROE	72.92
Roe5y	84.36
ROIC	45.95
Roic5y	45.43

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	20.5%
Cagr15y	21.06%
Cagr1y	16.48%
Cagr20y	18.8%
Cagr3y	4.64%
Cagr5y	1.99%
EPS Growth	25.7
EPS Growth Q	17.23
EPS Growth3 Y	17.86
EPS Growth5 Y	11.83
FCF Growth	27.81%
FCF Growth Q	12.66%
FCF Growth3 Y	33.47%
FCF Growth5 Y	10.21%
OCF Growth	24.96%
OCF Growth Q	11.89%
OCF Growth10 Y	16.71%
OCF Growth3 Y	25.5%
OCF Growth5 Y	10.2%
Revenue Growth	13.08x
Revenue Growth Q	14.26x
Revenue Growth3 Y	9.02x
Revenue Growth5 Y	9.24x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	EUR 1.35
Assets	EUR 2.9B
Cash	EUR 173.9M
Current Assets	EUR 1.2B
Current Liabilities	EUR 1.1B
Debt	EUR 958.8M
Debt EBITDA	EUR 0.7
Debt Equity	EUR 0.71
Debt FCF	EUR 1.02
Equity	EUR 1.3B
Interest Coverage	35.89
Liabilities	EUR 1.6B
Long Term Assets	EUR 1.7B
Long Term Liabilities	EUR 484.4M
Net Cash	EUR -784.8M
Net Cash By Market Cap	EUR -2.09
Net Debt EBITDA	EUR 0.59
Net Debt Equity	EUR 0.58
Net Debt FCF	EUR 0.84
Tangible Book Value	EUR 901.3M
Tangible Book Value Per Share	EUR 11.37

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	1.12
Inventory Turnover	4.34
Net Working Capital	EUR 572.9M
Quick ratio	0.69
Working Capital	EUR 133.8M
Working Capital Turnover	EUR 22.98

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	2.6%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	545.4%
1Y total return	16.47%
200-day SMA	549.1
3Y total return	14.57%
50-day SMA	502.6
50-day SMA vs 200-day SMA	50under200
5Y total return	10.36%
All Time High	665.8
All Time High Change	-27.02%
All Time High Date	2025-11-26
All Time Low	3.38
All Time Low Change	14,297.04%
All Time Low Date	1999-10-26
ATR	10.1
Ch YTD	-16.48
High	485.9
High52	665.8
High52 Date	2025-11-26
High52ch	-27.02%
Low	485.9
Low52	430.2
Low52 Date	2025-05-08
Low52ch	12.95%
Ma50ch	-3.32%
Price vs 200-day SMA	-11.51%
RSI	47.91
RSI Monthly	49.81
RSI Weekly	39.63
Sharpe ratio	0.36x
Sortino ratio	0.94
Total Return	2.6%
Tr YTD	-16.48
Tr15y	1,658.28%
Tr1m	-2.57%
Tr1w	0.83%
Tr3m	-10.68%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	EUR 1.2B
Operating Income Growth	14.85
Operating Income Growth Q	11.38
Operating Income Growth3 Y	14.49
Operating Income Growth5 Y	11.86
Operating margin	31.42

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	78,012,659%
Net Borrowing	27,232,299.6
Shares Insiders	0.99%
Shares Institutions	95.43%
Shares Qo Q	-0.4%
Shares Yo Y	-2.6%
Short Ratio	3.86

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	EUR 886.1M
Average Volume	8.6x
Bv Per Share	17.03
CAPEX	EUR -109.8M
Ch10y	545.4
Ch15y	1,658.3
Ch1m	-2.57
Ch1w	0.83
Ch1y	16.47
Ch20y	3,034.8
Ch3m	-10.68
Ch3y	14.57
Ch5y	10.36
Ch6m	-21.07
Change	-1.94%
Change From Open	0
Close	495.5
Days Gap	-1.94
Depreciation Amortization	126,179,289.5
Earnings Date	2026-05-05
EBIT	EUR 1.2B
EBITDA	EUR 1.3B
EPS	EUR 11.79
F Score	7
FCF	EUR 939.7M
FCF EV Yield	2.45x
Financing CF	-907,259,113
Fiscal Year End	December
Founded	1,983
Goodwill	349,448,532
Graham Number	69.51983
Graham Upside	-85.69
Income Tax	EUR 237.9M
Investing CF	-121,572,043
Is Primary Listing	0
Last Earnings Date	2026-05-05
Last Report Date	2026-03-31
Last Split Date	2015-06-16
Last Split Type	Forward
Lynch Fair Value	EUR 125
Lynch Upside	-74.21
Ma150	553.3
Ma150ch	-12.18%
Ma20	486.8
Ma20ch	-0.19%
Net CF	31,706,753
Open	485.9
P FCF Ratio	39.95
P OCF Ratio	35.77
Ppne	730,754,148.5
Price Date	2026-05-08
Price EBITDA	EUR 28
Ptbv Ratio	41.65
Relative Volume	0.79x
Revenue	3,856,098,194x
SBC By Revenue	1.39x
Share Based Comp	53,545,367
Tax By Revenue	6.17x
Tax Rate	20.03%
Tr20y	3,034.84%
Tr6m	-21.07%
Volume	0
Z Score	21.31

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does FRA/IX1 pay a dividend?

Capital-return profile for this ticker.

Performance

FRA/IX1 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns FRA/IX1?

Insider, institutional, and short-interest positioning.

Institutional ownership

+95.4%

Share of float held by funds and institutions

Insider ownership

+1.0%

Stake held by company insiders. Higher generally signals alignment.

Negative means the company is buying back shares.

Technical

FRA/IX1 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

47.9

Neutral momentum band

Price vs 200-day MA

-11.5%

50/200-day relationship not available

Beta (5Y)

n/a

Sensitivity to the broader market

Sharpe ratio

0.36

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About FRA/IX1

Hub-level FAQ points readers to the deeper analysis pages.

What is the current fra/IX1 stock rating?

fra/IX1 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full fra/IX1 analysis?

The full report lives at /stocks/fra/IX1/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for fra/IX1?

The latest report frames fra/IX1 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the fra/IX1 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.